tolnaftate has been researched along with Keratitis in 1 studies
Keratitis: Inflammation of the cornea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tolnaftate (TOL) is a selective fungicidal drug against Aspergillus spp." | 1.72 | Implementing polymeric pseudorotaxanes for boosting corneal permeability and antiaspergillus activity of tolnaftate: formulation development, statistical optimization, ex vivo permeation and in vivo assessment. ( Aziz, D; Makhlouf, A; Mohamed, S; Tayel, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aziz, D | 1 |
| Mohamed, S | 1 |
| Tayel, S | 1 |
| Makhlouf, A | 1 |
1 other study available for tolnaftate and Keratitis
| Article | Year |
|---|---|
Implementing polymeric pseudorotaxanes for boosting corneal permeability and antiaspergillus activity of tolnaftate: formulation development, statistical optimization, ex vivo permeation and in vivo assessment.
Topics: Antifungal Agents; Drug Carriers; Drug Delivery Systems; Eye Infections, Fungal; Humans; Keratitis; | 2022 |